1. Short title This Act may be cited as the Drug Price Transparency for Medicare Patients Act of 2019 . 2. Requirement that direct-To-Consumer television advertisements for prescription drugs and biological products include list price of such drugs and products Part A of title XI of the Social Security Act ( 42 U.S.C. 1301 et seq.) is amended by adding at the end the following new section: 1150C. Requirement that direct-To-Consumer television advertisements for prescription drugs and biological products include list price of such drugs and products (a) In general Subject to subsection (b), the Secretary, acting through the Administrator of the Centers for Medicare & Medicaid Services (referred to in this section as the Secretary ), shall require that each direct-to-consumer advertisement on television (including broadcast, cable, streaming, or satellite media) for a prescription drug or biological product for which payment is made available under title XVIII or XIX includes a written statement indicating the current list price for a 30-day supply of (or, if determined more appropriate by the Secretary, a typical course of treatment with) such drug or product as follows: The list price for a [30-day supply of, or a typical course of treatment with] [name of prescription drug or biological product] is [current list price]. If you have health insurance that covers drugs, your cost may be different. . Such statement shall be presented at the end of such an advertisement against a contrasting background for sufficient duration and in a size and style of font that allows such statement to be read easily. (b) Exception The requirement described in subsection (a) shall not apply with respect to a prescription drug or biological product that has a current list price less than $35 per month for a 30-day supply of, or a typical course of treatment with, such drug or product. (c) Identification of noncompliant drugs and products In the case that a direct-to-consumer advertisement described in subsection (a) does not include